6-BROMO-7-CHLORO-3,4-DIHYDROQUINOLIN-2(1H)-ONE, 95.0%, 250mg

(R)-7-(But-2-ynyl)-8-(3-(1,3-dioxoisoindolin-2-yl)piperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione, 98%, 10g

1'H-SPIRO[PIPERIDINE-4,4'-QUINOLIN]-2'(3'H)-ONE, 95.0%, 250mg

Diethyltrisulfane>98.0%(GC)5g

3-Fluoro-o-xylene, 98.0%, 5g

1,3,5-Trifluoro-2-(pentafluoroethyl)benzene, 95.0%, 1g

4-(Trimethylsilyl)biphenyl, 96.0%, 1g

(R)-2-Amino-2-(2-methoxypyridin-4-yl)ethanol dihydrochloride, 97.0%, 500mg

Methyl 1-(2-(benzyloxy)ethyl)cyclohexanecarboxylate, 5g

3-(4-Pyridyl)acrylic Acid>97.0%(GC)(T)5g

1-(4-Hydroxyphenyl)-2-thiourea, 95.0%, 1g

4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyridazine, 95.0%, 5g

Flat flange reaction vial, cylindrical, graduated, with tempering jacket KF connecting piece, DN 60, 500 ml, 90 mm, 1 Piece